Pilot evaluation of Orap (pimozide, R 6238) in child psychiatry.
D000293:Adolescent; D002648:Child; D002652:Child Behavior / Q000187:drug effects; D002653:Child Behavior Disorders / Q000188:drug therapy*; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy*; D008297:Male; D010868:Pimozide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011386:Projective Techniques; D011581:Psychological Tests; D012561:Schizophrenia, Childhood / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D014149:Tranquilizing Agents; D010868:Pimozide